The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 3 randomized placebo-controlled trial of donepezil for cancer-related cognitive impairment among breast cancer survivors: Results on patient-reported cognitive function from the Wake Forest NCI Community Oncology Research Program (NCORP) Research Base REMEMBER trial (WF97116).
 
Alayna E Ernster
No Relationships to Disclose
 
Emily Van Meter Dressler
Research Funding - Omada Health
Other Relationship - ICF
(OPTIONAL) Uncompensated Relationships - Society for Clinical Trials
 
W. Mark Brown
No Relationships to Disclose
 
Glenn Jay Lesser
Honoraria - SDP Oncology
Consulting or Advisory Role - Agios; Cancer Expert Now; IN8bio; Ono Pharmaceutical
Research Funding - cns pharmaceuticals; Denovo Biopharma; Global Coalition for Adaptive Research; Incyte; Novocure; Oblato
Other Relationship - ASCO; NCI
 
William P. Fusselman
No Relationships to Disclose
 
Vinay K. Gudena
Stock and Other Ownership Interests - Lilly; Merck
Honoraria - Daiichi Sankyo/Lilly
Consulting or Advisory Role - Cardinal Health; Daiichi Sankyo/Lilly; Genomic Health; Pfizer; Pfizer
 
Lynne I. Wagner
Consulting or Advisory Role - Athenex; Celgene
Travel, Accommodations, Expenses - Celgene
 
Heidi D. Klepin
Patents, Royalties, Other Intellectual Property - UptoDate contributor
 
Edward G. Shaw
Stock and Other Ownership Interests - Embodied Labs; Embodied Labs (I)
Patents, Royalties, Other Intellectual Property - Book royalties
 
Steve R. Rapp
No Relationships to Disclose